NOURIANZ: payments to doctors
Payments that named NOURIANZ as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $6.1M
- Providers
- 6,312
- Transactions
- 33,655
- Average per transaction
- $183
The per-transaction average — $183 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,312 providers the average total is $974, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Kyowa Kirin, Inc. | $6,130,385 | 99.7% |
| Kyowa Kirin Co., Ltd | $10,755 | 0.2% |
| Kyowa Kirin Services Ltd | $6,000 | 0.1% |